News about Engineering

New Invivoscribe Platform Targets KMT2A Rearrangements in AML Trials

Invivoscribe, a precision diagnostics company focused on measurable residual disease (MRD) testing, has expanded its oncology portfolio with the launch of the LeukoStrat KMT2A + MRD Assay and Software.

Engineering | 06/02/2026 | By Darshana |  158

India's 2026 Budget Sets Stage for Biopharmaceutical Manufacturing Boom: OPPI

The Organisation of Pharmaceutical Producers of India (OPPI) has described the Union Budget 2026 as a pivotal moment in India’s journey to becoming a global biopharmaceutical manufacturing leader.

Engineering | 02/02/2026 | By Darshana |  203

Eli Lilly Enters USD 1.12 Billion Gene-Editing Partnership with Seamless Therapeutics

Eli Lilly and Company has entered into a strategic collaboration worth up to USD 1.12 billion with private gene-editing company Seamless Therapeutics to develop next-generation therapies for hearing loss. The agreement strengthens Lilly’s push into genetic medicines and expands its pipeline beyond its core diabetes and obesity treatments.

Engineering | 29/01/2026 | By Darshana |  220

India - EU FTA Must Ensure Level Playing Field for Medical Device Makers: AiMeD

The proposed India–European Union Free Trade Agreement (FTA) has the potential to reshape India’s pharmaceutical and medical devices landscape, but industry leaders caution that its success will depend on how fairly it balances market access, regulatory alignment and domestic manufacturing interests.

Engineering | 28/01/2026 | By Darshana |  270

Alphatec Signs Strategic US Commercial Deal with Theradaptive, Backs Series B Expansion

Alphatec Holdings Inc (ATEC), a spine-focused medical technology company, and Theradaptive Inc, a clinical-stage regenerative medicine innovator, have entered into a definitive strategic partnership to advance next-generation biologic solutions for spine surgery.

Engineering | 14/01/2026 | By Darshana |  2282

Bayer Partners with Souffle Therapeutics to Develop Heart-Targeted siRNA Therapy

Bayer and Soufflé Therapeutics, a biotechnology company focused on developing cell-selective genetic medicines, have entered into a strategic collaboration and global licensing agreement to advance a heart-targeted small interfering RNA (siRNA) therapy for a rare form of dilated cardiomyopathy.

Engineering | 09/01/2026 | By Darshana |  621

Agilent Advances Sustainable Science with New India Refurbishment Centre

Agilent Technologies has inaugurated a new refurbishment centre in India, reinforcing its commitment to sustainable science and affordable innovation while enhancing customer engagement through an integrated, green-certified facility that also houses a dedicated education centre.

Engineering | 18/12/2025 | By News Bureau |  292

AlidaBio Launches EpiPlex Duo-Mod for Dual m6A-Inosine Mapping with RNA Expression Profiling

AlidaBio has launched the EpiPlex Duo-Mod Service, offering simultaneous m6A and inosine mapping with integrated gene expression profiling, enabling researchers to compare modification patterns and transcriptional changes from a single RNA input.

Engineering | 06/12/2025 | By Dineshwori |  198

Continuous Tableting Breakthrough: GEA and Hovione Introduce ConsiGma CDC Flex System

GEA and Hovione have expanded their long-standing partnership with the launch of the ConsiGma CDC Flex system — a next-generation continuous direct compression (CDC) platform designed to deliver greater flexibility, simplicity and cost-efficiency in the development and production of oral solid dosage forms.

Engineering | 04/12/2025 | By Dineshwori |  209

TQ Therapeutics GmbH Enters into Technology Access Agreement with Kytopen

Kytopen has strengthened its European footprint with a new partnership granting TQ Therapeutics on-site access to its non-viral Flowfect Tx cellular engineering platform. The collaboration will support integration of the technology into TQ’s CELLfinity platform.

Engineering | 04/12/2025 | By Dineshwori |  217